Search Results - "Singer, Josef"

Pre- or Perioperative Immunotherapy Combined with Chemotherapy Versus Chemotherapy Alone in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review.

Authors: Lehner, Sophie Singer, Josef Hackner, Klaus et al.

Source: Cancers. Jun2026, Vol. 18 Issue 12, p2002. 23p.

Retrospective Cohort Analysis of Treatment Patterns, Survival, and Cost‐Effectiveness in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma in Lower Austria (2018–2022).

Authors: Singer, Josef Gottsauner‐Wolf, Sandra Behrens, Doris A.

Source: Cancer Medicine. Mar2026, Vol. 15 Issue 3, p1-10. 10p.

Can Mindfulness-Based Stress Reduction Influence the Quality of Life, Anxiety, and Depression of Women Diagnosed with Breast Cancer? —A Review.

Authors: Ladenbauer, Severin Singer, Josef

Source: Current Oncology. Oct2022, Vol. 29 Issue 10, p7779-7793. 15p. 1 Diagram, 12 Charts.

On the applicability of the Southwell plot to plastic buckling.

Authors: Singer, Josef, 1923-

Source: Experimental Mechanics; June 1989, Vol. 29, p205-208, 4p

A case report of septic shock syndrome caused by S. pneumoniae in an immunocompromised patient despite of vaccination.

Authors: Singer, Josef Testori, Christoph Schellongowski, Peter et al.

Source: BMC Infectious Diseases. 6/22/2017, Vol. 17, p1-5. 5p. 1 Chart.

Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients.

Authors: Singer, Josef Le, Nguyen-Son Mattes, Daniel et al.

Source: Cancers. Sep2021, Vol. 13 Issue 17, p4312. 1p.

This result is not displayed to guests.
Login for full access.

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting

Authors: Singer, Josef Weichselbaumer, Marlene Stockner, Thomas et al.

Source: Molecular Immunology. Apr2012, Vol. 50 Issue 4, p200-209. 10p.

Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/ neu-positive tumour cells.

Authors: Karagiannis, Panagiotis Singer, Josef Hunt, James et al.

Source: Cancer Immunology, Immunotherapy. Jun2009, Vol. 58 Issue 6, p915-930. 16p. 1 Diagram, 4 Charts, 5 Graphs.

Using the P-CaRES Tool to Identify Palliative Care Needs in Patients with Life-Limiting Diseases: An Analysis of Internal Medicine Admissions.

Authors: Fidelsberger, Luise Fischer, Claudia Kreye, Gudrun et al.

Source: Journal of Clinical Medicine. Jun2025, Vol. 14 Issue 12, p4206. 17p.

Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.

Authors: FAZEKAS, JUDIT FÜRDÖS, IRENE SINGER, JOSEF et al.

Source: Oncology Letters. Oct2016, Vol. 12 Issue 4, p2271-2276. 6p.

Translating clinical trials from human to veterinary oncology and back.

Authors: Fürdös, Irene Fazekas, Judit Singer, Josef et al.

Source: Journal of Translational Medicine. Aug2015, Vol. 13 Issue 1, p1-7. 7p.

Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients.

Authors: Petricevic, Branka Laengle, Johannes Singer, Josef et al.

Source: Journal of Translational Medicine. 2013, Vol. 11 Issue 1, p2-29. 28p. 1 Chart, 8 Graphs.

Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination—A Retrospective Cohort Study.

Authors: Wirth, Stella Rosa Maria Podar, Klaus Pecherstorfer, Martin et al.

Source: Cancers. Jan2023, Vol. 15 Issue 2, p524. 12p.

Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma--A Single-Center Retrospective Cohort Study.

Authors: Huber, Fabian Zwickl-Traxler, Elisabeth Pecherstorfer, Martin et al.

Source: Current Oncology. Dec2021, Vol. 28 Issue 6, p4521-4529. 9p.

Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform.

Authors: Singer, Josef Manzano-Szalai, Krisztina Fazekas, Judit et al.

Source: OncoImmunology. 2016, Vol. 5 Issue 7, p1-1. 1p.

Palliative Radiotherapy Near the End of Life: An Analysis of Factors Influencing the Administration of Radiotherapy in Advanced Tumor Disease.

Authors: Le, Nguyen-Son Zeybek, Asli Hackner, Klaus et al.

Source: JCO Global Oncology. 4/18/2025, Vol. 11, p1-15. 15p.

Soluble FcɛRI: A biomarker for IgE‐mediated diseases.

Authors: Moñino‐Romero, Sherezade Lexmond, Willem S. Singer, Josef et al.

Source: Allergy. Jul2019, Vol. 74 Issue 7, p1381-1384. 4p. 2 Graphs.

Su.67. Establishing a Model for Examination of HER-2 Specific IgG and IgE Mediated Tumour Cell Killing

Authors: Singer, Josef Karagiannis, Panos Karagiannis, Sophia et al.

Source: Clinical Immunology. Apr2008 Supplement, Vol. 127, pS146-S146. 1p.

Real-world evidence of imatinib treatment in younger and older patients with chronic myeloid leukaemia: A retrospective single centre analysis.

Authors: Graf, Rebecca Kreye, Gudrun Pecherstorfer, Martin et al.

Source: Oncology Letters. Aug2025, Vol. 30 Issue 2, pN.PAG-N.PAG. 1p.